EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC-ND 4.0

The effect of perioperative erythropoietin‐stimulating agents and intravenous iron on patient outcomes following solid organ transplantation: A systematic review

Frank Lee, Quentin Eichbaum, Christine Cserti-Gazdewich, Darren Mullane, Frederick W Lombard, Jeremy W Jacobs iD, Katerina Pavenski, Marina Englesakis, Alexander Dotto, Terry Cho, Andrés Leonard-Reixa, Jacqueline Trudeau und 2 weitere

Transfusion Medicine · 2025

DOI: 10.1111/tme.70045 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Transfusion Medicine, 2025. Verfasst von Frank Lee und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Organ Transplantation, Iron, Hematinics, Anemia. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University of Toronto.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Solid organ transplant is associated with high rates of anaemia and transfusion, but there is little comparative data on interventions such as erythropoietin‐stimulating agents (ESAs) and intravenous (IV) iron. We conducted a systematic review examining the association of ESAs and IV iron with outcomes in adults undergoing solid organ transplant. This review was registered with PROSPERO (CRD42023474722). EMBASE and MEDLINE were searched from inception to April 11, 2025. Identified studies included adults (≥18 years of age) undergoing heart, liver, lung, or kidney transplant who received any ESA and/or IV iron before, during, or up to 1 month following solid organ transplant surgery compared to patients who did not. Article screening, full text review and data extraction were performed by two independent reviewers. The primary outcome of interest was transfusion volume, with secondary outcomes including haematological parameters, graft‐related outcomes and rates of major morbidity and mortality. Results were analysed descriptively and compiled into tables, and the risk of bias was assessed using the CLARITY framework. From 1693 studies identified, 22 were included (kidney transplant, n = 16; heart transplant or Left Ventricular Assist Device as a bridge to transplant, n = 4; liver transplant, n = 2). Due to heterogeneity in design, interventions and outcomes, meta‐analysis was not attempted. The quality of evidence was graded as Very Low. On the whole, a comprehensive strategy implementing ESAs and IV iron may improve haematological parameters and facilitate transfusion avoidance. High‐quality prospective studies assessing the impact of protocols for haemoglobin optimisation and transfusion avoidance in solid organ transplant are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Organ TransplantationIronHematinicsAnemiaErythropoietinHumansAdministration, IntravenousBlood Transfusion

Stichwörter der Autor:innen

erythropoietiniron compoundsorgan transplantationperioperative care

Substanzen

IronHematinicsErythropoietin

Autor:innen und Institutionen

  • Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
  • Department of Anesthesiology, Pharmacology, & Therapeutics, The University of British Columbia, Vancouver, British Columbia, Canada.
  • Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

ORCID-Profile: Jeremy W Jacobs

Förderung

  • University of Toronto

Zitieren

APA

Lee, F., Eichbaum, Q., Cserti-Gazdewich, C., Mullane, D., Lombard, F. W., Jacobs, J. W., Pavenski, K., Englesakis, M., Dotto, A., Cho, T., Leonard-Reixa, A., Trudeau, J., Shih, A. W., & Bartoszko, J. (2025). The effect of perioperative erythropoietin‐stimulating agents and intravenous iron on patient outcomes following solid organ transplantation: A systematic review. Transfusion Medicine. https://doi.org/10.1111/tme.70045

Vancouver

Lee F, Eichbaum Q, Cserti-Gazdewich C, Mullane D, Lombard FW, Jacobs JW, et al. The effect of perioperative erythropoietin‐stimulating agents and intravenous iron on patient outcomes following solid organ transplantation: A systematic review. Transfusion Medicine. 2025. doi:10.1111/tme.70045

BibTeX
@article{Lee2025,
  author = {Lee, Frank and Eichbaum, Quentin and Cserti-Gazdewich, Christine and Mullane, Darren and Lombard, Frederick W and Jacobs, Jeremy W and Pavenski, Katerina and Englesakis, Marina and Dotto, Alexander and Cho, Terry and Leonard-Reixa, Andrés and Trudeau, Jacqueline and Shih, Andrew W and Bartoszko, Justyna},
  title = {The effect of perioperative erythropoietin‐stimulating agents and intravenous iron on patient outcomes following solid organ transplantation: A systematic review},
  journal = {Transfusion Medicine},
  year = {2025},
  doi = {10.1111/tme.70045}
}
Kostenlos starten →